The N6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy

被引:342
|
作者
Dorn, Lisa E. [1 ]
Lasman, Lior [3 ]
Chen, Jing [4 ]
Xu, Xianyao [2 ]
Hund, Thomas J. [2 ]
Medvedovic, Mario [4 ]
Hanna, Jacob H. [3 ]
van Berlo, Jop H. [5 ,6 ]
Accornero, Federica [1 ]
机构
[1] Ohio State Univ, Dept Physiol & Cell Biol, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Biomed Engn, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[3] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel
[4] Univ Cincinnati, Dept Environm Hlth, Div Biostat & Bioinformat, Cincinnati, OH 45221 USA
[5] Univ Minnesota, Div Cardiovasc, Lillehei Heart Inst, Minneapolis, MN 55455 USA
[6] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA
基金
欧洲研究理事会; 美国国家卫生研究院; 以色列科学基金会; 英国医学研究理事会;
关键词
gene expression profiling; hypertrophy; mice; transgenic; RNA processing; post-transcriptional; GENE-EXPRESSION; NUCLEAR-RNA; GROWTH; N6-METHYLADENOSINE;
D O I
10.1161/CIRCULATIONAHA.118.036146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:N-6-Methyladenosine (m6A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. The role of m6A mRNA methylation in the heart is not known. Methods: To determine the role of m6A methylation in the heart, we isolated primary cardiomyocytes and performed m6A immunoprecipitation followed by RNA sequencing. We then generated genetic tools to modulate m6A levels in cardiomyocytes by manipulating the levels of the m6A RNA methylase methyltransferase-like 3 (METTL3) both in culture and in vivo. We generated cardiac-restricted gain- and loss-of-function mouse models to allow assessment of the METTL3-m6A pathway in cardiac homeostasis and function. Results: We measured the level of m6A methylation on cardiomyocyte mRNA, and found a significant increase in response to hypertrophic stimulation, suggesting a potential role for m6A methylation in the development of cardiomyocyte hypertrophy. Analysis of m6A methylation showed significant enrichment in genes that regulate kinases and intracellular signaling pathways. Inhibition of METTL3 completely abrogated the ability of cardiomyocytes to undergo hypertrophy when stimulated to grow, whereas increased expression of the m6A RNA methylase METTL3 was sufficient to promote cardiomyocyte hypertrophy both in vitro and in vivo. Finally, cardiac-specific METTL3 knockout mice exhibit morphological and functional signs of heart failure with aging and stress, showing the necessity of RNA methylation for the maintenance of cardiac homeostasis. Conclusions: Our study identified METTL3-mediated methylation of mRNA on N-6-adenosines as a dynamic modification that is enhanced in response to hypertrophic stimuli and is necessary for a normal hypertrophic response in cardiomyocytes. Enhanced m6A RNA methylation results in compensated cardiac hypertrophy, whereas diminished m6A drives eccentric cardiomyocyte remodeling and dysfunction, highlighting the critical importance of this novel stress-response mechanism in the heart for maintaining normal cardiac function.
引用
收藏
页码:533 / 545
页数:13
相关论文
共 50 条
  • [31] The N6-Methyladenosine mRNA Methylase METTL14 Regulates TLR4-mediated Intestinal Dysfunction in Parkinson's Disease
    Zou, J.
    Deng, Z.
    Lu, Z. Z.
    Wei, L.
    Wu, L. L.
    Yu, F.
    MOVEMENT DISORDERS, 2023, 38 : S654 - S654
  • [32] An mRNA methylase and demethylase regulate sorghum salt tolerance by mediating N6-methyladenosine modification
    Zheng, Hongxiang
    Dang, Yingying
    Gao, Yinping
    Li, Simin
    Wu, FengHui
    Zhang, Fangning
    Wang, Xuemei
    Du, Xihua
    Wang, Lei
    Song, Jie
    Sui, Na
    PLANT PHYSIOLOGY, 2024, 196 (04) : 3048 - 3070
  • [33] N6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy
    Feng, Siguo
    Zhang, Qiuyang
    Liu, Qing
    Huang, Chang
    Zhang, Huiying
    Wang, Fengsheng
    Zhu, Yue
    Jian, Qizhi
    Chen, Xue
    Jiang, Qin
    Yan, Biao
    DIABETES, 2025, 74 (01)
  • [34] The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1
    Shi, Yue
    Dou, Yanliang
    Zhang, Jianye
    Qi, Jie
    Xin, Zijuan
    Zhang, Mingxin
    Xiao, Yu
    Ci, Weimin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [35] N6-methyladenosine (m6A)-forming enzyme METTL3 controls UAF1 stability to promote inflammation in a model of colitis by stimulating NLRP3
    Lai, Yongqiang
    Liu, Junhao
    Hu, Xiao
    Zeng, Xiancheng
    Gao, Peng
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [36] N6-methyladenosine Methyltransferase METTL3 Enhances PTGER2 Expression to Increase Ovarian Cancer Stemness and Chemoresistance
    Lin, Yi-Bin
    Xu, Ben-Hua
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (09):
  • [37] N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway
    Wang, Lin-jian
    Xue, Yimeng
    Huo, Ran
    Yan, Zihan
    Xu, Hongyuan
    Li, Hao
    Wang, Jia
    Zhang, Qian
    Cao, Yong
    Zhao, Ji-zong
    JOURNAL OF BIOMEDICAL SCIENCE, 2020, 27 (01)
  • [38] N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway
    Lin-jian Wang
    Yimeng Xue
    Ran Huo
    Zihan Yan
    Hongyuan Xu
    Hao Li
    Jia Wang
    Qian Zhang
    Yong Cao
    Ji-zong Zhao
    Journal of Biomedical Science, 27
  • [39] Identification of Key Genes Mediated by N6-Methyladenosine Methyltransferase METTL3 in Ischemic Stroke via Bioinformatics Analysis and Experiments
    Liang, Tian
    Zhu, Lulu
    Yang, Jialei
    Huang, Xiaolan
    Lv, Miao
    Liu, Shengying
    Wen, Zheng
    Su, Li
    Zhou, Lifang
    MOLECULAR BIOTECHNOLOGY, 2025, 67 (01) : 160 - 174
  • [40] N6-Methyladenosine modification mediated by METTL3 promotes DNA-PKcs expression to induce anlotinib resistance in osteosarcoma
    Zhang, Yining
    Shen, Guohong
    Zhang, Dan
    Meng, Tingting
    Lv, Zhaorui
    Chen, Lei
    Li, Jianmin
    Li, Ka
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (02):